Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 2 1

Status

Recruiting 12Completed 7Unknown 4Terminated 3Not yet recruiting 3Active not recruiting 2

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 5Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Genitourinary 1

Conditions

Breast Neoplasms 1275Carcinoma, Non-Small-Cell Lung 783Neoplasms 767Colorectal Neoplasms 755Carcinoma, Hepatocellular 579Stomach Neoplasms 578Prostatic Neoplasms 501Lung Neoplasms 461Pancreatic Neoplasms 416Rectal Neoplasms 331Recurrence 312Neoplasm Metastasis 305Leukemia, Myeloid, Acute 289Multiple Myeloma 281Colonic Neoplasms 280Lymphoma 273Uterine Cervical Neoplasms 269Esophageal Neoplasms 267Ovarian Neoplasms 261Head and Neck Neoplasms 246Melanoma 240Precursor Cell Lymphoblastic Leukemia-Lymphoma 209Brain Neoplasms 195Lymphoma, Large B-Cell, Diffuse 184Nasopharyngeal Carcinoma 180Lymphoma, Non-Hodgkin 173Leukemia 173Liver Neoplasms 163Glioblastoma 158Urinary Bladder Neoplasms 153

Interventions

Valsartan 1Prednisone 1Infliximab 1Hydroxychloroquine 1Etanercept 1Antilymphocyte Serum 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Autoimmune Diseases × Clear all
NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown
290 enrolled

Arthritis, Rheumatoid, Autoimmune Diseases

NCT04791150 2021-05-10

Rheumatologic Adverse Events and Cancer Immunotherapy

Poitiers University Hospital

Phase NA Unknown
400 enrolled

Arthritis, Autoimmune Diseases, Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02765594 2017-09-20

HCQIgAN

Peking Union Medical College Hospital

Phase 4 Unknown
98 enrolled
Genitourinary

Autoimmune Diseases, Glomerulonephritis, Glomerulonephritis, IGA, Immune System Diseases, Kidney Diseases, Nephritis, Urologic Diseases

NCT00466843 2009-06-02

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Office of Rare Diseases (ORD)

Phase 2 Unknown
54 enrolled
MyeloidOther hematologic neoplasm

Autoimmune Diseases, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡